However, our observations that GR iKO mice suffered more severe acute colitis than Flox mice yet were partially protected from chronic inflammation–induced colon tumorigenesis suggest that early-phase immunosuppression may actually delay recovery from intestinal inflammation/damage and promote chronic inflammation–associated cancer formation. The gene discussed is NR3C1; the disease is cancer.